Jiangsu Lanfeng Biochemical Co., Ltd. Class A

Jiangsu Lanfeng Biochemical Co., Ltd. Class A

SSZSE:002513
4.82
CNY
-0.03
(-0.62%)
-0.84EPS
1.80BMarket Cap
Jiangsu Lanfeng Biochemical Co., Ltd. Class A
SZSE:002513
(Shenzhen Stock Exchange)

Recent

price

4.82

P/E

ratio

- -

div

yld

1.81%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
5.58
5.34
6
6.5
6.02
4.7
4.34
5.22
4.35
4.43
3.62
4.23
3.86
4.67
4.86
6.24
6.94
Revenue per Share
0.47
0.39
0.28
0.1
-0.18
-0.32
0.32
0.1
-2.57
-1.52
0.04
-1.44
-0.86
-0.89
-0.68
-0.51
-0.56
Basic EPS, GAAP
-0.86
-2.32
-1.75
-0.99
-0.27
0.66
0.51
-0.19
-0.13
0.48
0.06
-0.23
-0.26
-2.28
-0.46
-1.39
- -
Free Cash Flow per Basic Share
0.25
0.22
0.26
0.28
0.32
0.23
0.12
0.15
0.08
0.06
0.04
0.04
0.02
0.03
0.08
0.09
0.09
Dividend per Share
5.06
5.35
5.54
5.56
5.39
11.29
7.4
7.45
4.87
3.34
3.41
1.96
0.96
0.07
0.09
0.12
0.01
Book Value per Share
4.97
5.18
5.23
5.21
5.04
7.03
4.72
4.78
3.94
3.04
3.27
1.82
0.84
-0.09
-0.08
-0.05
-0.15
Tangible Book Value per Share
164
214
212
211
208
215
335
354
340
340
371
341
374
373
369
375
349
Basic Weighted Avg Shares
914
1,143
1,269
1,372
1,252
1,010
1,457
1,851
1,481
1,504
1,342
1,444
1,445
1,742
1,793
2,342
2,425
Sales/Revenue/Turnover
11.48
10.84
8.69
5.54
-0.37
-3.04
11.37
9.96
-7.28
1.63
-0.91
-12.01
-7.6
-12.52
-13.17
-5.78
-5.16
Operating Margin (%)
36
49
74
133
160
128
140
149
159
143
124
116
96
98
123
140
- -
Depreciation Expense
77
83
59
21
-37
-69
107
35
-875
-517
15
-491
-321
-332
-253
-191
-196
Net Income, GAAP
15.3
14.47
13.69
10.98
- -
- -
12.83
37.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
8.4
7.3
4.67
1.54
-2.99
-6.81
7.36
1.92
-59.06
-34.34
1.1
-34.02
-22.19
-19.08
-14.08
-8.13
-8.07
Profit Margin (%)
720
254
-268
-412
-286
-236
-217
-177
-272
-606
-311
-499
-677
-942
-1,026
-1,010
-1,110
Working Capital
153
82
- -
105
70
35
185
7
12
9
- -
- -
- -
409
433
356
281
LT Debt
1,078
1,140
1,182
1,186
1,149
2,407
2,517
2,533
1,657
1,135
1,160
667
358
251
313
355
286
Total Equity
7.88
5.72
3.7
0.96
- -
- -
2.95
1.51
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
8.78
6.88
5.08
2.94
- -
- -
4.86
2.26
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
11.63
7.53
5.1
1.78
-3.21
-3.87
4.36
1.4
-41.76
-37
1.29
-53.78
-62.62
-173.59
-874.34
-499.9
-2,234.89
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
250
215
254
LT Borrowings
344
362
279
LT Finance Leases
12
7
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
376
376
376
Market Capitalization
2,524
2,359
1,795

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,297
2,008
2,063
Cash, Cash Equivalents & STI
895
618
609
Accounts Receivable, Net
657
693
629
Inventories
297
210
329
Total Current Liabilities
3,307
2,990
3,173
Payables & Accruals
- -
- -
- -
ST Debt
250
215
254
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.92%
-16.1%
13.57%
Free Cash Flow
-23.87%
93.27%
204.52%
Net Income, GAAP
-652.84%
-698.65%
-24.54%
Sales/Revenue/Turnover
10.38%
12.35%
30.61%
Total Cash Common Dividend
10.28%
36.87%
11.06%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
378
471
578
367
1,793
2025
544
652
- -
512
2,342
2026
652
609
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.08
-0.32
-0.13
-0.2
-0.68
2025
-0.06
-0.07
- -
-0.33
-0.51
2026
-0.04
-0.13
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
0.03
0.03
0.08
2025
0.01
0.02
- -
0.05
0.09
2026
0.01
0.01
- -
- -
- -
Business
Jiangsu Lanfeng Bio-chemical Co., Ltd. (002513.SZ) researches, develops, produces and sells pesticides, fungicides, insecticides, herbicides, fine chemical intermediates and photovoltaic products including N-type TopCon batteries and modules primarily in China and internationally; its core agrochemical offerings encompass carbendazim, thiophanate-methyl, benomyl, cycloazinone, carbosulfan, acephate, cypermethrin, hexazinone, metazachlor, diuron, propamocarb hydrochloride, diethofencarb and iprodione, alongside chemical products such as sulfuric acid and surfactants. Founded in 1976 and headquartered at No. 2 Ningxia Road, Xinyi Economic Development Zone, Jiangsu Province, China, the company operates two main segments of agrochemicals and photovoltaics, serving agricultural and industrial customers across domestic markets and exports to Southeast Asia, Europe, Brazil, the United States and other regions; it employs approximately 1,573 people and maintains a provincial engineering technology research center and postdoctoral innovation practice base in Suzhou for R&D. In recent developments, its holding subsidiary Jiangsu Lanfeng Biochemical Co., Ltd. plans to increase capital by CNY 50 million through share expansion to introduce strategic investor Jiangsu Suhua Group Co., Ltd., enhancing business development as announced on December 23, 2024; the company also agreed to acquire a 51% stake in Solar N Plus New Energy Tech. Co., Ltd. to bolster its photovoltaics segment.